A critical breakthrough in cancer investigation is arising with the use of mini-antibodies to reactivate mutated p53. This vital tumor inhibitor protein is frequently inactivated in various forms of malignancies, https://macrobookmarks.com/story22089329/mini-antibodies-reactivate-p53-the-new-hope-for-cancer-management